Patients’ preference in the treatment of erectile dysfunction: a critical review of the literature
Author:
Publisher
Springer Science and Business Media LLC
Subject
Urology
Link
http://www.nature.com/articles/ijir201029.pdf
Reference41 articles.
1. Laumann EO, Nicolosi A, Glasser DB, Paik A, Gingell C, Moreira E et al. Sexual problems among women and men aged 40–80 y: prevalence and correlates identified in the Global Study of Sexual Attitudes and Behaviors. Int J Impot Res 2005; 17: 39–57.
2. Lewis RW, Fugl-Meyer KS, Bosch R, Fugl-Meyer AR, Laumann EO, Lizza E et al. Epidemiology/risk factors of sexual dysfunctions. J Sex Med 2004; 1: 35–39.
3. Hedelin H, Ströberg P . Treatment for erectile dysfunction based on patient-reported outcomes: to every man the PDE5 inhibitor that he finds superior. Drugs 2005; 65: 2245–2251.
4. Mirone V, Fusco F, Rossi A, Sicuteri R, Montorsi F . Tadalafil and vardenafil vs sildenafil: a review of patient-preference studies. BJU Int 2009; 103: 1212–1217.
5. Bai WJ . Tadalafil for erectile dysfunction: excellent safety and tolerance. Zhonghua Nan Ke Xue 2009; 15: 92–95.
Cited by 20 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Evaluation of prescribing pattern of phosphodiesterase-5 inhibitors and assessing effectiveness of sildenafil and tadalafil in patients with erectile dysfunction;Indian Journal of Pharmacy and Pharmacology;2022-01-15
2. Men’s beliefs about treatment for erectile dysfunction—what influences treatment use? A systematic review;International Journal of Impotence Research;2020-03-31
3. An update on emerging drugs for the treatment of erectile dysfunction;Expert Opinion on Emerging Drugs;2018-10-02
4. Non-invasive Management Options for Erectile Dysfunction When a Phosphodiesterase Type 5 Inhibitor Fails;Drugs & Aging;2018-02-20
5. Improving tadalafil dissolution via surfactant-enriched tablets approach: Statistical optimization, characterization, and pharmacokinetic assessment;Journal of Drug Delivery Science and Technology;2017-10
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3